
Glimecheck M 0.5 Tablet SR
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Glimepiride (0.5mg) + Metformin (500mg)
Overview Glimecheck M 0.5 Tablet SR
Diabetic patients using Glimecheck M 0.5 SR tablets, a dual-action antidiabetic medication, should adhere to prescribed dosage and timing for optimal blood glucose management. This medication, effective in controlling type 2 diabetes in adults, requires consistent use, even with seemingly controlled blood sugar, to mitigate risks such as kidney complications, vision impairment, neuropathy, and limb loss. Discontinuing treatment necessitates prior physician consultation. Successful management relies heavily on a comprehensive approach encompassing this medication, alongside a balanced diet, regular exercise, and weight management as guided by your healthcare provider. Commonly reported is hypoglycemia (low blood sugar), characterized by symptoms such as tremors, sweating, dizziness, and headaches. Regular meals, along with readily available glucose sources (e.g., sugary snacks or juice), are crucial for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include gastrointestinal distress (nausea, diarrhea, stomach pain), altered taste perception, headaches, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating individuals require medical consultation before using this medication. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential components of treatment.
Uses of Glimecheck M 0.5 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimecheck M 0.5 Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimecheck M 0.5 Tablet SR with a meal.
Common Side effects of Glimecheck M 0.5 Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimecheck M 0.5 Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimecheck M 0.5 Tablet SR with a meal.
How Glimecheck M 0.5 Tablet SR works:
Glimecheck M 0.5 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in the body.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimecheck M 0.5 Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimecheck M 0.5mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Glimecheck M 0.5 mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Glimecheck M 0.5 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimecheck M 0.5 Tablet SR is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimecheck M 0.5 mg sustained-release tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimecheck M 0.5 Tablet SR :
Should you forget a Glimecheck M 0.5 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimecheck M 0.5 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
